- Home
- GOODO vs MRK Comparison
GOODO vs MRK Comparison
Compare GOODO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GOODO
Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Current Price
Current Price
Company Overview
Basic Information| Metric | GOODO | MRK |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | 72 | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 268.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GOODO | MRK |
|---|---|---|
| Price | $20.28 | $117.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $121.00 |
| AVG Volume (30 Days) | N/A | ★ 13.8M |
| Earning Date | N/A | 02-03-2026 |
| Dividend Yield | N/A | ★ 2.79% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | N/A | ★ 7.28 |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | N/A | $5.02 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | ★ N/A | $16.75 |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | N/A | $73.31 |
| 52 Week High | N/A | $122.66 |
Technical Indicators
Market Signals| Indicator | GOODO | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 63.74 |
| Support Level | $20.02 | $106.03 |
| Resistance Level | $20.87 | $122.46 |
| Average True Range (ATR) | 0.41 | 3.13 |
| MACD | -0.04 | 0.82 |
| Stochastic Oscillator | 23.81 | 68.87 |
Price Performance
Historical ComparisonAbout GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).